MAM-specific fluorescence calcium sensor and use thereof

Abstract

The present disclosure relates to a Mitochondria-Associated endoplasmic reticulum Membrane (MAM)-specific fluorescence calcium sensor and the use thereof. The present disclosure can surmount the limitations of a conventional technique in that verification of calcium migration through MAM requires separate measurements of calcium ion concentrations within ER and mitochondria and situational explanations of the phenomena, and can directly measure concentrations in the paths through which calcium ions move to exclude influences on calcium ion changes through numerous different calcium ion channels existing in mitochondria, thereby providing a convenient and accurate MAM-specific calcium ion sensor.

Claims

1. A Mitochondria-Associated endoplasmic reticulum Membrane(MAM)-specific fluorescent calcium sensor comprising the following structures: (a) a first fluorescent complementary structure in which a linker peptide and a fragment of a calcium ion-sensitive fluorescent sensor protein sequentially bind to a fragment of an Endoplasmic Reticulum(ER)-targeting protein, and (b) a second fluorescent complementary structure in which a linker peptide and a fragment of a calcium ion-sensitive fluorescent sensor protein sequentially bind to a fragment of a mitochondria-targeting protein, wherein the calcium ion-sensitive fluorescent sensor protein bound to the fragment of the Endoplasmic Reticulum(ER)-targeting protein is a split GCaMP protein which is encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 6, and wherein the calcium ion-sensitive fluorescent sensor protein bound to the fragment of the mitochondria-targeting protein is a split GCaMP protein which is encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 5.

2. The sensor according to claim 1, wherein the ER-targeting protein is suppressor of actin 1 (SAC1).

3. The sensor according to claim 2, wherein a fragment of the SAC1 protein consists of amino acids 521 to 587 of a full-length SAC1 protein.

4. The sensor according to claim 1, wherein the mitochondria-targeting protein is A Kinase Anchoring Protein 1(AKAP1).

5. The sensor according to claim 4, wherein a fragment of the AKAP1 protein consists of amino acids 34 to 63 of a full-length AKAP1 protein.

6. The sensor according to claim 1, wherein the mitochondria-targeting protein is Mitofusin 1(MFN1).

7. The sensor according to claim 3, wherein the fragment of the SAC1 protein is encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 1.

8. The sensor according to claim 5, wherein the fragment of the AKAP1 protein is encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 2.

9. The sensor according to claim 6, wherein the MFN1 protein is encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 3.

10. The sensor according to claim 1, wherein the linker peptide is encoded by a polynucleotide consisting of 1 to 8 repeats of a base sequence of SEQ ID NO: 4.

11. The sensor according to claim 10, wherein the linker peptide is encoded by a polynucleotide consisting of 2 to 4 repeats of the base sequence of SEQ ID NO: 4.

12. A method of sensing Mitochondria-Associated endoplasmic reticulum Membrane (MAM)-specific calcium using the sensor of claim 1.

Description

DESCRIPTION OF DRAWINGS

(1) FIG. 1A is a schematic diagram illustrating a process of designing a MAM-specific fluorescent calcium sensor of the present disclosure.

(2) FIG. 1B is a schematic diagram illustrating a principle of operating a MAM-specific fluorescent calcium sensor of the present disclosure.

(3) FIG. 2 is a schematic diagram illustrating a difference between a MAM-specific fluorescent calcium sensor of the present disclosure and a conventional method.

(4) FIG. 3A is a schematic diagram illustrating a structure of an FOS/JUN leucin zipper-inserted nucleic acid molecule for experimental verification.

(5) FIG. 3B is a schematic diagram illustrating splitting points in candidate genes for split GCaMP of the present disclosure.

(6) FIG. 4 shows the fluorescent reactivity of split GCaMP with respect to calcium ion stimulation, expressed by candidate genes for the split GCaMP of the present disclosure.

(7) FIG. 5 shows the reactivity of spGCaMP144/149, which is the most effective combination among the split GCaMP candidate group of the present disclosure, with respect to calcium ion stimulation taken by a time-lapse imaging technique, and numerical quantification thereof.

(8) FIG. 6A shows recombinant expression vectors for a MAM-specific fluorescent marker of the present disclosure.

(9) FIG. 6B shows recombinant expression vectors for a MAM-specific fluorescent marker of the present disclosure.

(10) FIG. 7A shows a result of comparing intracellular fluorescent patterns between a MAM-specific fluorescent marker of the present disclosure and conventional ER/mitochondrial fluorescent markers to confirm the effectiveness of the MAM-specific fluorescent marker of the present disclosure.

(11) FIG. 7B shows a result of analyzing Mander's colocalization coefficients thereof.

(12) FIG. 7C shows results of fluorescent line analysis thereof.

(13) FIG. 8A shows recombinant expression vectors of fluorescent complementary structures constituting a MAM-specific fluorescent calcium sensor of the present disclosure.

(14) FIG. 8B shows recombinant expression vectors of fluorescent complementary structures constituting a MAM-specific fluorescent calcium sensor of the present disclosure.

(15) FIG. 9 shows the reactivity of the recombinant expression vector of FIG. 8 with respect to calcium ion stimulation, taken by a time-lapse imaging technique, after the recombinant expression vector is transfected to HEK293 cells, and numerical quantification of the reactivity.

MODES OF THE DISCLOSURE

(16) The present disclosure provides a MAM-specific fluorescent calcium sensor, which includes (a) a first fluorescent complementary structure in which a linker peptide and a fragment of a calcium ion-sensitive fluorescent sensor protein sequentially bind to a fragment of an ER-targeting protein, and (b) a second fluorescent complementary structure in which a linker peptide and a fragment of a calcium ion-sensitive fluorescent sensor protein sequentially bind to a fragment of a mitochondria-targeting protein (refer to FIGS. 1A and 1B).

(17) Conventionally, since genetic materials capable of measuring a concentration of calcium ions have been found, many research groups have conducted studies to measure a calcium concentration in a specific organelle in cells by applying various genetic methods and focusing on organelles having a membrane structure, such as the ER, mitochondria, a lysosome, etc.

(18) For example, to measure the migration of calcium ions through MAM as a main path of transferring calcium ions between the ER and mitochondria and an increase in calcium ion concentration in mitochondria thereby, there is a method of estimating the migration of calcium ions through MAM by measuring changes in calcium concentration in each of the ER and mitochondria using an ER-targeting fluorescent calcium ion sensor protein and an mitochondria-targeting fluorescent calcium ion sensor protein and then collectively using the measurement results (refer to FIG. 2).

(19) However, this method not only should be performed by several steps, but also is unable to directly prove that the delivery of calcium ions in the ER to the mitochondria is specifically “through MAM” among a plurality of mitochondrial calcium ion paths, and the only thing that this method can prove accurately is introduction of calcium ions into the mitochondria. That is, since, due to characteristics of the ER and mitochondria in which various calcium ion channels besides MAM are present, the possibility that the migration of calcium ions is achieved through a channel other than MAM cannot be excluded, there is a limitation in that the migration of calcium ions through MAM cannot be directly proved.

(20) In the present disclosure, a biomolecular fluorescence complementation (BiFC) system is a tool for analyzing the fluorescence exhibited when a complete fluorescent protein is formed, wherein protein fragment complementation is applied to a fluorescent protein, the fluorescent protein is then divided into N-terminus and C-terminus fragments and expressed with each one of two proteins whose mutual interaction is to be investigated, and then the two proteins come close to each other for interaction, the two fragments of the fluorescent protein are combined, thereby forming a complete fluorescent protein, and the present disclosure is the first to introduce such BiFC technique for MAM-specific fluorescent calcium sensing.

(21) In the present disclosure, an ER-targeting protein constituting a first fluorescent complementary structure has no particular limit as long as it can specifically target the ER, and may be, for example, annexin or an inositol 1,4,5-triphosphate receptor (IP3R), and preferably suppressor of actin 1 (SAC1).

(22) Here, a fragment of the SAC1 protein may consist of amino acids 521 to 587 of a full-length SAC1 protein, and may be encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 1, or a base sequence having at least 60%, 70%, 80%, 90% or 95% homology therewith.

(23) In the present disclosure, a mitochondria-targeting protein constituting the second fluorescent complementary structure does not have a particular limitation as long as it can specifically target mitochondria, and may be, for example, translocase of outer mitochondrial membrane 20 (TOM20) or voltage dependent anion channel 1 (VDAC1), and preferably A Kinase Anchoring Protein 1 (AKAP1) or Mitofusin 1 (MFN1).

(24) Here, a fragment of the AKAP1 protein may consist of amino acids 34 to 63 of a full-length AKAP1 protein, and may be encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 2, or a base sequence having at least 60%, 70%, 80%, 90% or 95% homology therewith. In addition, the MFN1 protein may be encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 3, or a base sequence having at least 60%, 70%, 80%, 90% or 95% homology therewith.

(25) In the present disclosure, the linker peptide has no limit as long as it can link the targeting protein to the split GCaMP, and may be encoded by a polynucleotide including 1 to 8 repeats, preferably 2 to 4 repeats, of a base sequence of SEQ ID NO: 4 or a base sequence having at least 60%, 70%, 80%, 90% or 95% homology therewith.

(26) Here, the term “percent sequence homology” refers to a degree of identity between a randomly given sequence and a target sequence.

(27) In the present disclosure, the calcium ion-sensitive fluorescent sensor protein is a fluorescent protein which can be used in BiFC analysis for analyzing protein-protein interaction, dimerization or oligomerization in cells, and the type of the calcium ion-sensitive fluorescent sensor protein is not particularly limited as long as it can measure fluorescence produced in response to calcium ions. The calcium ion-sensitive fluorescent sensor protein is preferably GCaMP, PeriCaM or Cameleon, and is designed with various sizes according to the type, characteristic, stability or fluorescence intensity of a protein.

(28) More preferably, the calcium ion-sensitive fluorescent sensor protein is a fluorescent calcium indicator (GCaMP) fragment encoded by a polynucleotide consisting of a base sequence of SEQ ID NO: 5 or 6. The GCaMP is a calcium ion-sensitive fluorescent sensor protein having a structure in which Calmodulin, which transforms in response to calcium ions, is fused with a green fluorescent protein (GFP).

(29) In addition, the present disclosure provides a recombinant expression vector which expresses an ER- or mitochondria-targeting protein as a fusion protein with a fluorescent protein via a linker peptide.

(30) The “vector” used herein may be any material which can deliver or express a nucleic acid molecule in a host cell or a test specimen. Accordingly, the vector may be a replicon, for example, a plasmid, a phage or a cosmid, into which a PCR product or any nucleic acid segment which is introduced into cells and integrated into a cell genome can be inserted. Generally, a vector may be replicated when binding to a suitable regulatory element. A vector backbone suitable for being used in the present disclosure may be manufactured to be expressed by a promoter showing high expression efficiency in mammalian cells, and may include, for example, a CMV promoter. Preferably, pEGFP-N1 and pEGFP-C3 vectors disclosed in FIGS. 6A and 6B are used as a backbone.

(31) In the present disclosure, there is no limit to a method of manufacturing a fusion gene by cloning a desired gene to the vector backbone, and the method may be, for example, blunt-ended termini or stagger-ended termini for ligation, digestion with a restriction enzyme for providing suitable termini, ligation of cohesive ends as needed, treatment with an alkaline phosphatase to avoid unfavorable bonding, and enzyme ligation.

(32) In the present disclosure, the targeting protein-linker peptide is expressed in the form of a fusion protein expressed as one polypeptide by peptide bonding with the N- or C-terminus region of a calcium ion-sensitive fluorescent sensor protein, and since the linker peptide may bind to both the C-terminus or the N-terminus of the fluorescent protein, the targeting protein-linker peptide may be expressed in the form of (calcium ion-sensitive fluorescent sensor protein terminus region)-linker or linker-(calcium ion-sensitive fluorescent sensor protein terminus region).

(33) In the present disclosure, it can be confirmed that by transfecting cells with a recombinant expression vector of the present disclosure and culturing the same to express a protein in the cells, and measuring fluorescence in response to MAM-specific calcium, it is possible to target a specific location in the cells and accurately analyze a protein-protein interaction. Here, fluorescence may be measured using a fluorescence microscope, a confocal microscope, etc.

(34) In addition, the present disclosure may provide a method of measuring a MAM-specific calcium concentration by sensing MAM-specific calcium using the MAM-specific fluorescent calcium sensor.

(35) Hereinafter, to help in understanding the present disclosure, exemplary examples will be proposed. However, the following examples are merely provided to more easily understand the present disclosure, and not to limit the present disclosure.

EXAMPLES

Example 1. Construction of Split GCaMP

(36) 1-1. Insertion of Leucine Zipper Sequence for Experimental Verification

(37) {circle around (1)} Fos Leucine Zipper

(38) A leucine zipper sequence (the 279 bp gene sequence corresponding to the sequence of amino acids 118 to 210) of a mouse Fos gene (FBJ osteosarcoma oncogene, Mus musculus, Gene ID: 14281) was amplified based on a pEGFP-C3 vector and inserted as a Fos leucine zipper sequence of a recombinant gene.

(39) To this end, a mouse cDNA library was used as a template and subjected to PCR using the following primers.

(40) TABLE-US-00001 Fos-(118aa-210aa) forward primer: (SEQ ID NO: 10) 5′-CCG GGA ATT CTG GGC AGA GCG CAG AGC ATC G-3′ Fos-(118aa-210aa) reverse primer: (SEQ ID NO: 11) 5′-CGC GGA TCC TCA AAG GTC ATC GGG GAT CTT GCA G-3′

(41) The amplified DNA was treated with EcoR I and BamH I restriction enzymes and then inserted into a pEGFP-C3 vector subjected to cleavage with EcoR I and BamH I restriction enzymes using a T4 ligase, thereby constructing a pEGFP-C3-Fos(118aa-210aa) vector.

(42) {circle around (2)} Jun Leucine Zipper

(43) To construct a Jun leucine zipper sequence vector which can interact with the Fos leucine zipper sequence, a leucine zipper sequence (the 186 bp gene sequence corresponding to the sequence of amino acids 257 to 318) of a mouse Jun gene (Jun protooncogene, Mus musculus, Gene ID: 16476) was amplified based on a pEGFP-C3 vector and inserted as a Jun leucine zipper sequence of a recombinant gene.

(44) To this end, a mouse cDNA library was used as a template and subjected to PCR using the following primers.

(45) TABLE-US-00002 Jun-(257aa-318aa) forward primer: (SEQ ID NO: 12) 5′-CCG GAA TTC TGA AGG CAG AGA GGA AGC GCA TG-3′ Jun-(257aa-318aa) reverse primer: (SEQ ID NO: 13) 5′-CGC GGA TCC TCA GTG GTT CAT GAC TTT CTG-3′

(46) The amplified DNA was treated with EcoR I and BamH I restriction enzymes and then inserted into a pEGFP-C3 vector previously subjected to cleavage with EcoR I and BamH I restriction enzymes using a T4 ligase, thereby constructing a pEGFP-C3-Jun(257aa-318aa) vector.

(47) 1-2. Construction of Candidate Split GCaMP Gene

(48) Based on known GCaMP6s sequence and an enhanced GFP (EGFP) structure, to deduce the optimal combination of split GCaMP genes exhibiting fluorescence and calcium ion reactivity of GCaMP, four types of recombinant vectors for 7 split GCaMP genes were constructed as follows.

(49) In each combination, a gene corresponding to the amino terminus (N-terminus) of the protein sequence of GCaMP was replaced with an EGFP gene of a pEGFP-C3-Fos (118aa-210aa) vector, and a gene corresponding to the carboxy terminus (C-terminus) was replaced with an EGFP gene of a pEGFP-C3-Jun(257aa-318aa) vector (refer to FIGS. 3A and 3B).

(50) TABLE-US-00003 Combination 1 (balanced pair) (spGC149)-Fos(118aa-210aa) vector spGC-N-terminus forward primer: (SEQ ID NO: 14) 5′-gggaccggtgccaccatgggttctcatcatcatcatcatcatg-3′ spGC149 reverse primer: (SEQ ID NO: 15) 5′-ggaagatctgacttgtacagctcgtccatgcc-3′ (spGC144)-Jun(257aa-318aa) vector spGC144 forward primer: (SEQ ID NO: 16) 5′-gggaccggtgccaccatggtgagcaagggcgag-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′ Combination 2 (unbalanced pair #1) (spGC100)-Fos(118aa-210aa) vector spGC-N-terminus forward primer: (SEQ ID NO: 14) 5′-gggaccggtgccaccatgggttctcatcatcatcatcatcatg-3′ spGC100 reverse primer: (SEQ ID NO: 18) 5′-ggaagatctgagaagaagatggtgcgctcctg-3′ (spGC105)-Jun(257aa-318aa) vector spGC105 forward primer: (SEQ ID NO: 19) 5′-gggaccggtgccaccatgtacaagacccgcgccgag-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′ Combination 3 (unbalanced pair #2-1) (spGC188)-Fos(118aa-210aa) vector spGC-N-terminus forward primer: (SEQ ID NO: 14) 5′-gggaccggtgccaccatgggttctcatcatcatcatcatcatg-3′ spGC188 reverse primer: (SEQ ID NO: 20) 5′-ggaagatctgagatgggggtgttctgctgg-3′ (spGC172)-Jun(257aa-318aa) vector spGC172 forward primer: (SEQ ID NO: 21) 5′-gggaccggtgccaccatggacggcggcgtgcagc-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′ Combination 4 (unbalanced pair #2-2) (spGC188)-Fos(118aa-210aa) vector spGC-N-terminus forward primer: (SEQ ID NO: 14) 5′-gggaccggtgccaccatgggttctcatcatcatcatcatcatg-3′ spGC188 reverse primer: (SEQ ID NO: 20) 5′-ggaagatctgagatgggggtgttctgctgg-3′ (spGC199)-Jun(257aa-318aa) vector spGC199 forward primer: (SEQ ID NO: 22) 5′-gggaccggtgccaccatgcactacctgagcgtgcagtcc-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′

(51) The GCaMP6s gene was used as a template and subjected to DNA amplification with each of the above-listed combinations of corresponding primers. Subsequently, the amplified DNA was treated with Age I and Bgl II restriction enzymes. The DNA subjected to treatment with the restriction enzymes was inserted into each of a pEGFP-C3-Fos(118aa-210aa) vector and a pEGFP-C3-Jun(257aa-318aa) vector from which an EGFP gene part was removed using Age I and Bgl II restriction enzymes. Here, a T4 ligase was used.

Example 2. Confirmation of Calcium Reactivity of Split GCaMP

(52) 2-1. Transfection of Recombinant Vector

(53) HEK293 cells cultured on a glass-bottomed dish for 12 hours were transfected with the four gene combinations constructed in Example 1, using a lipofectamine 2000 reagent in accordance with a manufacturer's protocol.

(54) 2-2. Real-Time Observation Using Fluorescence Microscope

(55) After the transfection, HEK293 cells were cultured in 10% fetal bovine serum (FBS)-containing DMEM under conditions of 37° C. and 5% CO.sub.2 for 24 hours, and then the medium was replaced with a calcium-free imaging buffer (145 mM NaCl, 2.5 mM KCl, 10 mM glucose, 10 mM HEPES pH 7.4, 1 mM MgCl.sub.2), followed by a time-lapse imaging test performed using a fluorescence microscope every second.

(56) As stimuli for a calcium reaction, ionomycin (Sigma-Aldrich) and a CaCl.sub.2 aqueous solution were treated to have a final working concentration of 10 μM and 1 mM, respectively.

(57) As a result, as shown in FIG. 4, the combination of spGCaMP144 and spGCaMP149 among the four bimolecular combinations of split GCaMP was identified as the optimal combination exhibiting green fluorescence in response to calcium ions in the same manner as the conventional GCaMP.

(58) In addition, the reactivity to calcium ions in cells transfected with a (spGC149)-Fos(118aa-210aa) vector and a (spGC144)-Jun(257aa-318aa) vector was investigated by time-lapse fluorescent microscopy. Here, time-lapse fluorescent microscopy was used to observe a time-lapse fluorescence change every 10 seconds for total of approximately 150 seconds. The Fos(118aa-210aa) and Jun(257aa-318aa) sequences used in Example 1 were used to target all of GCaMP and BiFC used herein to a nucleus, GCaMP used as a single molecule was nuclear specifically targeted by linkage with 3 repeats of the NLS sequence, and the GCaMP-NLS sequence is represented by SEQ ID NO: 7.

(59) As a result, as shown in FIG. 5, it was confirmed that the combination of spGCaMP144 and spGCaMP149 can be used as a bimolecular fluorescent calcium sensor which has reactivity at a similar level to that of GCaMP6 being widely used and can produce fluorescence in response to calcium ions only when the members of the combination are in proximity to each other.

Example 3. Construction of MAM-Specific Recombinant Nucleic Acid Molecule

(60) 3-1. Construction of Mitochondria-Targeting, Recombinant Nuclear Acid Molecule Using AKAP1

(61) {circle around (1)} Insertion of Mitochondria-Targeting Sequence

(62) A mitochondria-targeting sequence (the 90 bp gene sequence corresponding to the sequence of amino acids 34 to 63) of a mouse Akap1 gene (A kinase (PRKA) anchor protein 1, Mus musculus, Gene ID: 11640) was amplified using a pEGFP-N1 vector, thereby constructing a mitochondria-targeting vector.

(63) To this end, a mouse cDNA library was used as a template and subjected to PCR using primers of the following sequences.

(64) TABLE-US-00004 AKAP1-(34aa-63aa) forward primer: (SEQ ID NO: 23) 5′-ctagctagccaccatggcaatccagagcgttcg-3′ AKAP1-(34aa-63aa) reverse primer: (SEQ ID NO: 24) 5′-ccgctcgagttattacgagagaaaaaccaccaccagcc-3′

(65) The amplified DNA was treated with Nhe I and Xho I restriction enzymes and inserted into a pEGFP-N1 vector that were previously subjected to cleavage with Nhe I and Xho I restriction enzymes using a T4 ligase, thereby constructing a pEGFP-N1-AKAP1(34aa-63aa) vector.

(66) {circle around (2)} Replacement of Fluorescent Protein Gene

(67) A Venus gene was used as a template and subjected to PCR using the following primers.

(68) TABLE-US-00005 Venus155-N1 forward primer: (SEQ ID NO: 25) 5′-cgcggatcccaccatgaagcagaagaacggcatcaag-3′ Venus155-N1 reverse primer: (SEQ ID NO: 26) 5′-aaatatgcggccgctttacttgtacagctcgtccatgc-3′

(69) The amplified gene was treated with BamH I and Not I restriction enzymes and then inserted, using a T4 ligase, into a pEGFP-N1-AKAP1(34aa-63aa) vector previously treated with BamH I and Not I restriction enzymes to truncate an EGFP gene part, thereby constructing a pVenus(155-C)-N1-AKAP1(34aa-63aa) vector in which the EGFP gene was replaced with a BiFC gene.

(70) {circle around (3)} Insertion of Linker Sequence

(71) The following 60 bp linker sequence was used independently, or repeats thereof were used as needed.

(72) TABLE-US-00006 linker sequence: (SEQ ID NO: 4) 5′-gacccaaccaggtcagcgaattctggagcaggagcaggagcag gagcaatactctcccgt-3′

(73) Specifically, a linker sequence having the following sequence was synthesized, and the synthesized oligo DNA was treated with Xho I and Sal I restriction enzymes and inserted into a pVenus(155-C)-N1-AKAP1(34aa-63aa) vector previously treated with a Xho I restriction enzyme using a T4 ligase, thereby constructing a pVenus(155-C)-linker-AKAP1(34aa-63aa) vector (refer to FIG. 6A).

(74) TABLE-US-00007 linker oligo DNA: (SEQ ID NO: 27) 5′-ccgctcgag (gacccaaccaggtcagcgaattctggagcaggagcaggagcaggagca atactctcccgt)n gtcgac-3′

(75) 3-2. Construction of Mitochondria-Targeting, Recombinant Nucleic Acid Molecule Using MFN1

(76) {circle around (1)} Insertion of Mitochondria-Targeting Sequence

(77) A mouse Mfn1 gene (Mitofusin 1, Mus musculus, Gene ID: 67414) was amplified using a pEGFP-C3 vector, thereby constructing a mitochondria-targeting vector.

(78) To this end, a mouse cDNA library was used as a template and subjected to PCR using primers having the following sequences.

(79) TABLE-US-00008 MFN1 forward primer: (SEQ ID NO: 28) 5′-ccggaattctggcagaaacggtatctccactgaag-3′ MFN1 reverse primer: (SEQ ID NO: 29) 5′-cgcggatccttaggattctccactgctcggg-3′

(80) The amplified DNA was treated with EcoR I and BamH I restriction enzymes and inserted into a pEGFP-C3 vector previously subjected to cleavage with EcoR I and BamH I restriction enzymes using a T4 ligase, thereby constructing a pEGFP-C3-MFN1 vector.

(81) {circle around (2)} Replacement of Fluorescent Protein Gene

(82) A Venus gene was used as a template and subjected to PCR using the following primers.

(83) TABLE-US-00009 Venus N172-C3 forward primer: (SEQ ID NO: 30) 5′-gggaccggtgccaccatggtgagcaagggcgag-3′ Venus N172-C3 reverse primer: (SEQ ID NO: 31) 5′-ggaagatctgactcgatgttgtggcggatc-3′

(84) The amplified DNA was treated with Age I and Bgl II restriction enzymes, and then inserted into a pEGFP-C3-MFN1 vector previously treated with Age I and Bgl II restriction enzymes to cleave an EGFP gene using a T4 ligase, thereby constructing a pVenus(N-172)-C3-MFN1 vector in which an EGFP gene was replaced with a BiFC gene.

(85) {circle around (3)} Insertion of Linker Sequence

(86) Similarly as in Example 3-1, a 60 bp linker sequence was used independently, or repeats thereof were used as needed, and an oligo DNA synthesized by the same method as used in Example 3-1 was treated with Xho I and Sal I restriction enzymes and inserted into a pVenus(N-172)-C3-MFN1 vector previously treated with an Xho I restriction enzyme using a T4 ligase, thereby constructing a pVenus(N-172)-linker-MFN1 vector (refer to FIG. 6B).

(87) TABLE-US-00010 linker oligo DNA: (SEQ ID NO: 27) 5′-ccgctcgag (gacccaaccaggtcagcgaattctggagcaggagcaggagcaggagca atactctcccgt)n gtcgac-3′

(88) 3-3. Construction of ER-Targeting, Recombinant Nucleic Acid Molecule Using SAC1

(89) {circle around (1)} Insertion of ER-Targeting Sequence

(90) An ER-targeting sequence (the 204 bp gene sequence corresponding to the sequence of amino acids 521 to 587) of a mouse Sac 1 gene (suppressor of actin mutations 1 (SAC1)-like (yeast), Mus musculus, Gene ID: 83493) was amplified using a pEGFP-C3 vector and then inserted as an ER-targeting sequence of a recombinant gene.

(91) To this end, a mouse cDNA library was used as a template and subjected to PCR using the following primers.

(92) TABLE-US-00011 SAC1-(521aa-587aa) forward primer: (SEQ ID NO: 32) 5′-cggggtaccgttcctggcgttgcctatcatc-3′ SAC1-(521aa-587aa) reverse primer: (SEQ ID NO: 33) 5′-cgcggatcctcagtctatcttttctttctggaccag-3′

(93) The amplified DNA was treated with Kpn I and BamH I restriction enzymes and then inserted into a pEGFP-C3 vector previously subjected to cleavage with Kpn I and BamH I restriction enzymes using a T4 ligase, thereby constructing a pEGFP-C3-SAC1(521aa-587aa) vector.

(94) {circle around (2)} Replacement of Fluorescent Protein Gene

(95) A Venus gene was used as a template and subjected to PCR using the following primers.

(96) TABLE-US-00012 Venus149C-C3 forward primer: (SEQ ID NO: 34) 5′-gggaccggtgccaccatgaacgtctatatcaccgccgac-3′ Venus149C-C3 reverse primer: (SEQ ID NO: 35) 5′-ggaagatctgacttgtacagctcgtccatgcc-3′

(97) The amplified gene was treated with Age I and Bgl II restriction enzymes and then inserted, using a T4 ligase, into a pEGFP-C3-SAC1(521aa-587aa) vector previously treated with Age I and Bgl II restriction enzymes to truncate an EGFP gene part, thereby constructing a pVenus(149-C)-C3-SAC1(521aa-587aa) vector in which the EGFP gene is replaced with a BiFC gene.

(98) {circle around (3)} Insertion of Linker Sequence

(99) Similarly as in Example 3-1, a 60 bp linker sequence was used independently, or repeats thereof were used as needed, and an oligo DNA synthesized by the same method as used in Example 3-1 was treated with Xho I and Sal I restriction enzymes and inserted into a pVenus(149-C)-C3-SAC1(521aa-587aa) vector previously treated with an Xho I restriction enzyme using a T4 ligase, thereby constructing a pVenus(149-C)-linker-SAC1(521aa-587aa) vector (refer to FIG. 6B).

(100) 3-4. Verification of MAM Targeting

(101) {circle around (1)} Preparation and Observation of Sample for Microscopy

(102) To verify MAM targeting of the bimolecular MAM-specific fluorescent marker prepared in the present disclosure, HEK293 cells were transfected with the constructed pVenus(N-172)-linker-MFN1 vector, pVenus(149-C)-linker-SAC1(521aa-587aa) vector and a mitochondrial or ER fluorescent marker gene vector, thereby preparing a microscope sample.

(103) Afterward, as a result of observing an intracellular fluorescence pattern using a fluorescence microscope, as shown in FIG. 7A, it was confirmed that a MAM-specific biomolecular fluorescent marker using these targeting sequences in cells selectively targets the contact site between the ER and mitochondria (MAM).

(104) {circle around (2)} Analysis of MAM Targeting

(105) To analyze a MAM targeting level of the bimolecular MAM-specific fluorescent marker constructed in the present disclosure, the fluorescent images taken using the prepared microscope samples were analyzed using Image J, which is the software for universal image analysis distributed by NIH.

(106) First, according to a method used in conventional MAM research, an overlapping spot in fluorescence of an ER-targeting fluorescent material labeling an ER matrix and a mitochondria-targeting fluorescent material labeling a mitochondrial matrix was extracted, and used for determining the Mander's colocalization coefficient with a fluorescence pattern of a biomolecular MAM-specific fluorescent marker.

(107) As a result, as shown in FIG. 7B, it was confirmed that, in all investigated cells, the bimolecular MAM-specific fluorescent marker of the present disclosure exhibits fluorescence at a higher level at the overlapping spot (overlapped) in which fluorescence of mitochondria and ER are overlapped than each of the mitochondrial and ER fluorescent markers.

(108) In addition, line analysis was performed to analyze patterns of a MAM-specific fluorescent marker, an ER fluorescent marker, and a mitochondrial fluorescent marker in a section in which a MAM-specific fluorescent signal is detected.

(109) As a result, as shown in FIG. 7C, it was confirmed that the MAM-specific biomolecular fluorescent marker of the present disclosure very accurately labels MAM present at a boundary (a region in which solid lines of the graph intersect, indicated by arrow) between mitochondria (blue fluorescence) and ER (red fluorescence).

Example 4. Construction of MAM-Specific Calcium Ion Sensor Recombinant Expression Vector

(110) Based on the pVenus(155-C)-linker-AKAP1(34aa-63aa) vector constructed in Example 3, a GCaMP6s gene was used as a template and subjected to PCR amplification using the following primers used in Combination 1 of Example 1-2.

(111) TABLE-US-00013 spGC144 forward primer: (SEQ ID NO: 16) 5′-gggaccggtgccaccatggtgagcaagggcgag-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′

(112) Afterward, the PCR product was treated with BamH I and Not I restriction enzymes and inserted, using a T4 ligase, into a pVenus(155-C)-linker-AKAP1(34aa-63aa) vector which was previously treated with BamH I and Not I restriction enzymes to truncate a Venus(155-C) gene part, thereby constructing an AKAP1(34aa-63aa)-linker-spGC144 vector (refer to FIG. 8A).

(113) Likewise, based on the pVenus(N-172)-linker-MFN1 vector constructed in Example 3, a GCaMP6s gene was used as a template and subjected to PCR amplification using the following primers used in Combination 1 of Example 1-2.

(114) TABLE-US-00014 spGC144 forward primer: (SEQ ID NO: 16) 5′-gggaccggtgccaccatggtgagcaagggcgag-3′ spGC-C-terminus reverse primer: (SEQ ID NO: 17) 5′-ggaagatctgacttcgctgtcatcatttgtacaaac-3′

(115) Afterward, the PCR product was treated with Age I and Bgl II restriction enzymes and inserted, using a T4 ligase, into a pVenus(N-172)-linker-MFN1 vector which was previously treated with Age I and Bgl II restriction enzymes to truncate a Venus(N-172) gene part, thereby constructing a spGC144-linker-MFN1 vector.

(116) In addition, based on the pVenus(149-C)-linker-SAC1(521aa-587aa) vector constructed in Example 3, a GCaMP6s gene was used as a template and subjected to PCR amplification using the following primers used in Combination 1 of Example 1-2.

(117) TABLE-US-00015 spGC-N-terminus forward primer: (SEQ ID NO: 14) 5′-gggaccggtgccaccatgggttctcatcatcatcatcatcatg-3′ spGC149 reverse primer: (SEQ ID NO: 15) 5′-ggaagatctgacttgtacagctcgtccatgcc-3′

(118) Afterward, the PCR product was treated with Age I and Bgl II restriction enzymes and inserted, using a T4 ligase, into a pVenus(149-C)-linker-SAC1(521aa-587aa) vector which was previously treated with Age I and Bgl II restriction enzymes to truncate a Venus(149-C) gene part, thereby constructing a spGC149-linker-SAC1(521aa-587aa) vector.

Example 5. Confirmation of Calcium Reactivity of MAM-Specific Calcium Ion Sensor Protein

(119) 5-1. Transfection of Recombinant Gene Vector

(120) HEK293 cells cultured on a glass-bottomed dish for 12 hours were transfected with each of the AKAP1(34aa-63aa)-linker-spGC144 vector and the spGC149-linker-SAC1(521aa-587aa) vector, which were the recombinant expression vectors constructed in Example 4, using a lipofectamine 2000 reagent in accordance with a manufacturer's protocol.

(121) 5-2. Real-Time Observation Using Fluorescence Microscope

(122) After the transfection, HEK293 cells were cultured in DMEM containing 10% Fetal Bovine Serum (FBS) under conditions of 37° C. and 5% CO.sub.2 for 24 hours, the culture medium was replaced with a calcium-free imaging buffer (145 mM NaCl, 2.5 mM KCl, 10 mM glucose, 10 mM HEPES pH 7.4, 1 mM MgCl.sub.2), and then a time-lapse imaging experiment was performed every second using a fluorescence microscope.

(123) Ionomycin (Sigma-Aldrich) and inositol-1,4,5-trisphosphate (IP3) were used for treatment as stimuli for a MAM-specific calcium reaction to have a final working concentration of 10 μM, or CaCl.sub.2 was used for treatment as a stimulus for a MAM-specific calcium reaction to have a final working concentration of 1 mM.

(124) As a result, as shown in FIG. 9, it was confirmed that the MAM-specific calcium ion sensor protein (MAM-spGCaMP) expressed in the HEK293 cells can detect a calcium change in practice, as suggested by an increase in fluorescence upon treatment with IP3 or CaCl.sub.2.

(125) It would be understood by those of ordinary skill in the art that the above description of the present disclosure is exemplary, and the exemplary embodiments disclosed herein can be easily modified into other specific forms without departing from the technical spirit or making changes to essential features of the present disclosure. Therefore, the exemplary embodiments described above should be interpreted as illustrative and not limiting in any aspect.

INDUSTRIAL APPLICABILITY

(126) With the MAM-specific calcium ion sensor according to the present disclosure, a change in calcium ion can be simply and accurately confirmed by directly measuring a calcium concentration at a path through which calcium ions are migrated, thus conventional limitations can be overcome, and the sensor can be useful in various basic and clinical studies by sensing a change in calcium ions in an organism.